首页> 外国专利> derivatives of n - (3 - ylamide pyrrolidine inhibitors of reabsorption as serotonin and noradrenaline

derivatives of n - (3 - ylamide pyrrolidine inhibitors of reabsorption as serotonin and noradrenaline

机译:n-(3- ylamide pyrrolidine)重吸收抑制剂的羟色胺和去甲肾上腺素的衍生物

摘要

Compounds of formula () and their pharmaceutically and / or veterinary acceptable derivatives. In the form,R1 stands for H, C1 to C6 alkyl, - c() y, C3 to C8 cycloalkyl, aryl, het, (C1 to C4 alkyl) or het ("C1 to C4 alkyl"),Among them, cycloalkanes, aryls or hetes are optionally substituted, and at least one of the substituents is independently selected among C1-C8 alkyl substituents, C1-C8 alkyl substituents, oh, halogenated, CF3, ocf3, ScF3 and hydroxyalkyl among c1-c6alkyl substituents.("alkoxy en C1-C4" ("alkyle en C1-C6") and ("alkyle en C1-C4");R2 represents an aryl or heteroaryl group, each selectively substituting at least one substituent, an alkyl substituent from C1 to C8, an alkyloxy group from C1 to C8, oh, halogenated, C3, ocf3, ScF3, a hydroxyalkyl group from C1 to C6, ("alkyl group from C1 to C4") ("alkyl group from C1 to C6") and ("alkyl group from C1 to C4") ("alkyl group from C1 to C4");R3 is an alkyl group of C1 to C6, a cycloalkyl group of C3 to C8 ("a cycloalkyl group of C3 to C8") ("an alkyl group of C1 to C6"),Aryl, het, aryl (- C1-C4 alkyl) or het (- C1-C4 alkyl),Among them, cycloalkyl, aryl or heptyl groups are selectively substituted, at least one of which is independently selected in c1-c6alkyl substituent, c1-c6alkyloxy, oh, halogenation, C3, ocf3, ScF3, hydroxyalkyl, c1-c6alkyl, (c1-c6alkyl) and () C1-C4 alkyl () C1-C4 alkyl ();X stands for s or O;Y stands for H, c1-c6alkyl, aryl, het, aryl ("C1-C4 alkyl") or, het ("C1-C4 alkyl");N equals 1 or 2;But if n equals 1, m equals 0 or 1, and if n equals 2, m equals 0, orIf M equals 0, * indicates the operating center. The compound of the invention has activity as a serotonin and norepinephrine reuptake inhibitor and can be used in various therapeutic fields, such as urinary incontinence.
机译:式()的化合物及其药学和/或兽医学可接受的衍生物。 R1的形式代表H,C1至C6烷基,-c()y,C3至C8环烷基,芳基,het(C1至C4烷基)或het(“ C1至C4烷基”),其中,环烷烃,芳基或杂原子任选地被取代,并且至少一个取代基独立地选自C 1 -C 6烷基取代基中的C 1 -C 8烷基取代基,C 1 -C 8烷基取代基,卤素,CF 3,ocf 3,ScF 3和羟基烷基。烷氧基C 1 -C 4”(“烷基C 1 -C 6”)和(“烷基C 1 -C 4”); R 2代表芳基或杂芳基,各自选择性地取代至少一个取代基,C 1至C 8的烷基取代基, C1至C8的烷氧基,被卤代的C3,ocf3,ScF3,C1至C6的羟烷基,(“ C1至C4的烷基”)(“ C1至C6的烷基”)和(“烷基C1至C4”的烷基(“ C1至C4的烷基”); R3为C1至C6的烷基,C3至C8的环烷基(“ C3至C8的环烷基”)(“烷基C1至C6”的基团),芳基,杂芳基(-C1-C4烷基)或杂芳基(-C1-C 4烷基)中,环烷基,芳基或庚基被选择性取代,其中至少一个独立地选自c1-c6烷基取代基,c1-c6烷氧基,OH,卤代基,C3,ocf3,ScF3,羟烷基,c1-c6烷基,(c1-c6烷基)和()C1-C4烷基()C1-C4烷基(); X代表s或O; Y代表H,c1-c6烷基,芳基,杂基,芳基(“ C1-C4烷基” )或het(“ C1-C4烷基”); N等于1或2;但是如果n等于1,m等于0或1,并且如果n等于2,m等于0,或者如果M等于0,则*表示操作中央。本发明的化合物具有5-羟色胺和去甲肾上腺素再摄取抑制剂的活性,并且可以用于各种治疗领域,例如尿失禁。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号